<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02994901</url>
  </required_header>
  <id_info>
    <org_study_id>EA1/260/16</org_study_id>
    <nct_id>NCT02994901</nct_id>
  </id_info>
  <brief_title>Cause and Importance of the Age-dependent Sarcopenia</brief_title>
  <acronym>SARCOPENIA</acronym>
  <official_title>Cause and Importance of the Age-dependent Sarcopenia With a Blood Based Bioenergetics &amp; Cytokine Profiling Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Institute of Human Nutrition</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this cross-sectional study is to evaluate the difference in cytokine profiling
      approach and mitochondrial function between geriatric sarcopenic patients (group 1) and
      geriatric non-sarcopenic patients (group 2) and healthy (group 3) geriatric participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study participants (group 1&amp;2) are assessed during the hospital stay and age-matched controls
      (group 3) will be recruited through Flyers.

      The investigators aim to isolate and cryopreserve peripheral blood mononuclear cells (PBMCs)
      from whole blood to perform functional assays on mitochondrial respiratory capacity and ROS.
      Furthermore, the investigators will investigate the association between biomarkers and
      frailty, quality of life, functional performance, fatigue and risk of depression.

      The investigators hypothesize that this profiling approach will allow the evaluation of the
      progression of age-dependent sarcopenia and uncover novel therapeutic targets.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in mitochondrial respiratory capacity of peripheral blood mononuclear cells (PBMCs) using Oxygraph-2k respirometry</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (validated questionnaire)</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frailty Status according to Fried et.al. criteria</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional limitations (single validated questionnaire)</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Geriatric patient with Sarcopenia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Geriatric Patient without Sarcopenia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>healthy control group</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Group 1: sarcopenic patient Group 2: non-sarcopenic patient Group 3: healthy control
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 60 and 85 years

          -  Informed written consent

          -  Normal cognitive status according to Mini-Mental State Examination (MMSE ≥ 24 points)

          -  Life expectancy of &gt; 3 months according to treating doctor

          -  without implanted Defibrillation

          -  without acute Sepsis

          -  without neurodegenerative diseases, especially amyotrophic lateral sclerosis (ALS) and
             Huntington

        Exclusion Criteria:

          -  Age &lt; 60 years or &gt; 85 years

          -  Lack of informed written consent

          -  Low cognitive status according to Mini-Mental State Examination (MMSE &lt; 24 points)

          -  Life expectancy of &lt; 3 months according to treating doctor

          -  Implanted Defibrillation

          -  Acute Sepsis

          -  neurodegenerative diseases, especially amyotrophic lateral sclerosis (ALS) and
             Huntington
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristina Norman, PD Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite Research Group on Geriatrics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristina Norman, PD Dr.</last_name>
    <phone>0049/30450565139</phone>
    <email>kristina.norman@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristina Franz, MScIS</last_name>
    <phone>0049/30450565137</phone>
    <email>kristina.franz@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charite University Medicine, Research Group on Geriatrics</name>
      <address>
        <city>Berlin</city>
        <zip>13347</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Norman, PD Dr.</last_name>
      <phone>+4930450565139</phone>
      <email>kristina.norman@charite.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Marzetti E, Calvani R, Cesari M, Buford TW, Lorenzi M, Behnke BJ, Leeuwenburgh C. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol. 2013 Oct;45(10):2288-301. doi: 10.1016/j.biocel.2013.06.024. Epub 2013 Jul 8. Review.</citation>
    <PMID>23845738</PMID>
  </reference>
  <reference>
    <citation>Léger B, Derave W, De Bock K, Hespel P, Russell AP. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res. 2008 Feb;11(1):163-175B. doi: 10.1089/rej.2007.0588.</citation>
    <PMID>18240972</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2016</study_first_submitted>
  <study_first_submitted_qc>December 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2016</study_first_posted>
  <last_update_submitted>December 13, 2016</last_update_submitted>
  <last_update_submitted_qc>December 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Kristina Norman</investigator_full_name>
    <investigator_title>PD Dr.</investigator_title>
  </responsible_party>
  <keyword>Sarcopenia</keyword>
  <keyword>Geriatrics</keyword>
  <keyword>Biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

